Metagenomi Therapeutics, Inc. · NASDAQ:MGX
Wapnick Pamela received 24,000 Metagenomi Therapeutics, Inc. shares as an award (Form 4)
Traded Apr 1, 2026 · Filed Apr 3, 2026
On Apr 1, 2026, Wapnick Pamela (Chief Financial Officer) received 24,000 Metagenomi Therapeutics, Inc. shares as an award, leaving 211,375 shares. Filed Apr 3, 2026 (Form 4).
- Awarded
- 24,000 shares
- Holding after
- 211,375 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Apr 1, 2026 | Common Stock | Award | 24,000 | 211,375 | Direct |
Source
Related
- Metagenomi Therapeutics, Inc.
- Wapnick Pamela
- Metagenomi Therapeutics, Inc. shareholders
- Form 4 · Wapnick Pamela · Sep 10, 2026
- Form 4 · Wapnick Pamela · Jun 10, 2026
- Form 4 · Reid Laurence · Sep 11, 2026
- Form 4 · Wein Matthew · Sep 10, 2026
- Form 4 · Irish Jian · Sep 10, 2026
- Schedule 13G · Thomas Brian C. · Sep 10, 2026
- Form 4 · Irish Jian · Jun 10, 2026